GAMMA Investing’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Buy |
2,355
+374
| +19% | +$47K | 0.02% | 680 |
|
|
2025
Q1 | $219K | Sell |
1,981
-314
| -14% | -$34.7K | 0.02% | 719 |
|
|
2024
Q4 | $313K | Buy |
2,295
+557
| +32% | +$76K | 0.03% | 526 |
|
|
2024
Q3 | $200K | Buy |
1,738
+185
| +12% | +$21.3K | 0.02% | 624 |
|
|
2024
Q2 | $214K | Buy |
1,553
+395
| +34% | +$54.4K | 0.03% | 479 |
|
|
2024
Q1 | $160K | Buy |
1,158
+310
| +37% | +$42.8K | 0.03% | 470 |
|
|
2023
Q4 | $119K | Buy |
+848
| New | +$119K | 0.03% | 477 |
|